The 2026 systematic review found oral doxycycline works about as well as azithromycin for moderate-to-severe acne vulgaris. For adults with persistent acne that continues past the teen years, researchers still lack strong data on clearance, relapse, and best dosing. Acne vulgaris is an inflammatory condition that clogs pores and causes pimples and tender lumps. The review followed PRISMA methods for randomized trials, according to the full 2026 review in PMC.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How did doxycycline compare with azithromycin?
- How is doxycycline meant to be used?
- Why is persistent adult acne a special gap?
- What should future adult studies answer?
How did doxycycline compare with azithromycin?
Treatment success was similar for the two drugs in moderate-to-severe acne. PubMed reports an odds ratio of 1.28 favoring doxycycline, with wide confidence limits and no statistical difference, in PubMed's 2026 summary. Inflammatory-lesion reduction also showed no clear winner.
The average difference was small and not significant, while control treatments scored better on overall severity improvement. For an adult weighing options, the takeaway is practical. Neither drug emerged as the stronger choice for clearing moderate-to-severe breakouts.
How is doxycycline meant to be used?
Skin guidance does not support doxycycline alone. Clinical Advisor describes AAD guidance to pair it with benzoyl peroxide or a retinoid, in Clinical Advisor's coverage of the AAD guidance.
Treatment is also meant to stay short, often around three to four months. The goal is to gain control while limiting bacterial resistance. Adults considering therapy can use these points as a checklist:.
- ask whether a combination plan fits instead of antibiotic-only treatment
- ask how response will be judged and when to stop or switch
- plan sun protection, because photosensitivity can require sun avoidance
Why is persistent adult acne a special gap?
Adult acne often behaves differently from teen acne, with flares along the lower face and jaw and slower resolution. Most trial groups were younger or mixed, leaving fewer results specific to adults with ongoing disease. One adult-women trial points to the gap.
In the FASCE trial of 133 adult women, daily spironolactone produced higher treatment success at six months than daily doxycycline. That result does not make spironolactone right for every adult. It shows that adult persistent acne needs its own comparisons, not borrowed teen data.
What should future adult studies answer?
Dose is a leading question. Wiley reports that 40 mg per day beat placebo and matched higher daily doses for inflammatory-lesion reduction, in Wiley's 2025 network meta-analysis. Lower effective doses could matter for tolerability and longer adult courses. Studies should test whether that dose holds up in adults with persistent disease.
Durability is the other missing piece. Current trials are often short and varied, with little data on relapse after stopping, long-term control, and resistance in adult care. The FDA label notes more gastrointestinal and skin reactions with doxycycline than with azithromycin pulse therapy, including photosensitivity that calls for sun avoidance. Adults using it should plan daily sun habits and prompt contact for severe rash, blistering, stomach pain, or vomiting.
You Might Also Like
- The 2026 Review of Topical Antibiotic Monotherapy for Acne: What Researchers Still Need to Learn for Adults With Persistent Acne
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: Product-Claim Questions for Adults With Persistent Acne
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Product-Claim Questions for Adults With Persistent Acne